Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Double blind, randomized, parallel group, multicentre study to evaluate the effects of manidipine 20 mg vs. amlodipine 10 mg and the combination of manidipine 10 mg plus delapril 30 mg vs. amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure in hypertensive patients.

Next Previous
X
Search
Trial Profile

Double blind, randomized, parallel group, multicentre study to evaluate the effects of manidipine 20 mg vs. amlodipine 10 mg and the combination of manidipine 10 mg plus delapril 30 mg vs. amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure in hypertensive patients.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2013

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Manidipine (Primary) ; Amlodipine; Delapril
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Acronyms MANTRA

    • Most Recent Events

    • 21 Jun 2010 Results reported at the 20th European Meeting on Hypertension.
    • 03 Feb 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top